Transcript of "H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)"
Get more info on this report!H1N1 (Swine Influenza) Market Assessment (Latest Data, CompanyProfiles, Implications for Immunoassays and Molecular Assays)May 1, 2009The outbreak of H1N1 (swine flu) highlighted the public health importance of improvedtesting techniques and providing market opportunities for manufacturers of diagnostictests and other products related to the disease. These conclusions and others appear ina new report released from Kalorama Information: Swine Flu Market Alert byKaloramas lead analyst, Shara Rosen.Regardless of the eventual severity of the epidemic, there will be distinct market impacton both immunoassay and molecular test makers, according to the report. The makersof certain tests will benefit both in terms of sales and more broadly in recognition thattheir products play a vital role in making the public health community significantly betterprepared for this possible pandemic than 1968 or before.The report examines: Market Impact likely for immunoassays and molecular testing. Lessons from previous epidemics, likely impact on both immunoassays and molecular testing. Overview of the H1N1 strain as compared to other. Immunoassay and Molecular Test Products Available on the Market Developments in the last few days of significance to the diagnostic industry. Profiles of nearly 25 specific manufacturers active in this space.The report focuses almost exclusively on the in vitro diagnostic industry as it applies towork being done by commercial entities and products that are either in development orhave been brought to market.The market assessment provided has been assembled based on publicly availableinformation. Company sales data and other quantitative evaluations of the markets forflu diagnostics have been developed based on publicly available information and areexpressed in US dollars, no adjustments have been made for currency exchangefluctuations.Under normal circumstances, a report of this genre would be assembled frominformation derived from primary and secondary sources. However, in the short time it
took to research and write this report, almost all of the major scientific and industryexperts were occupied with the extraordinary task of preparing for a pandemic.Therefore the information contained in this report has been assembled from a vast arrayof scientific and market publications, government sources, analyzed by a professionalanalyst.TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY Background Exhibit 1: Flu Epidemics Compared to Present 1918-Today Scope And Methodology Point of View Information SourcesCHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS Influenza Overview Overview of Virus Types What’s So Special About This Latest Flu? Flu Therapeutics WHO Global Influenza Preparedness PlanCHAPTER THREE: FLU DIAGNOSTICS Background Exhbit 2: Influenza Test Innovations, 2009 (Company, Technology, Test Details, Status) Immunoassays o Rapid Testing o Market Performance of Rapid Test o New Entrant Possiblity o Conclusion: Impact of Swine Flu on Rapid Testing Molecular Assays o Molecular Influenza Detection Techniques o PCR, Sequencing or Both o Lessons and Market Impact of the H5N1 EpidemicCHAPTER FOUR: PROGNOSIS FOR A/H1N1 Background Pandemic - Where? When? o 1976 Hsw1N1 Swine Flu Case o Comparing Past Flu Epidemics to 2009 o International Reaction Swine Flu and the IVD Industry
o Origin of Flu Virus Mixes o PCR Test Development o Late-Breaking Research Developments o Use of Rapid Tests in Current EpidemicCHAPTER FIVE: COMPANIES AND PRODCUTS IMPACTED BY SWINE FLUEPIDEMIC Immunoassays o 3M Medical Diagnostics o Becton, Dickinson and Company (BD) o Genzyme Corporation o Inverness Medical Innovations o Meridian Bioscience, Inc. o Quidel Corporation o Remel, Inc. o Response Biomedical Corporation Molecular Tests o Arbor Vita Corporation o CombiMatrix Molecular Diagnostics (CMDX) o Diagnostic HYBRIDS, Inc. (DHI) o eGene Inc. o Eiken Chemical Co., Ltd o Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI) o Lab21 o Laboratory Corporation of America Holdings (LabCorp) o Luminex Corporation o Nanogen o Prodesse Inc. o Qiagen N.V. o Seegene Inc. o Veredus Laboratories PteAvailable immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2241990US: 800.298.5699
UK +44.207.256.3920Intl: +1.240.747.3093Fax: 240.747.3004